Pegvisomant

Details

Files

Generic Name:

Pegvisomant

Project Status:

Complete

Therapeutic Area:

acromegaly

Manufacturer:

Pfizer Canada Inc.

Brand Name:

Somavert

Project Line:

Reimbursement Review

Project Number:

SR0050-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

acromegaly

Recommendation Type:

Do not list

Final Recommendation:

August 2, 2006

Recommendation:

(tentative)

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : January 25, 2006